Factor V Mutation Screening F5 G1691A
Understanding Factor V Mutation Screening
The Factor V Mutation Screening F5 G1691A represents a cutting-edge genetic diagnostic tool designed to identify the Factor V Leiden mutation, one of the most common inherited risk factors for abnormal blood clotting. This sophisticated screening targets the specific G1691A point mutation in the Factor V gene, which results in resistance to activated protein C – a natural anticoagulant in your bloodstream. The presence of this genetic variation significantly elevates your susceptibility to developing venous thromboembolism and other serious clotting disorders.
What This Test Detects and Measures
Our advanced Factor V Mutation Screening utilizes Real Time PCR technology to precisely identify the G1691A genetic mutation in the F5 gene. This comprehensive analysis detects:
- The specific point mutation at position 1691 in the Factor V gene
- Genetic predisposition to activated protein C resistance
- Inherited thrombophilia risk factors
- Homozygous or heterozygous mutation status
Clinical Significance of Factor V Leiden
The Factor V Leiden mutation represents the most prevalent inherited thrombophilia condition worldwide. Individuals carrying this genetic variation have a 3-8 times higher risk of developing venous thrombosis compared to those without the mutation. The screening provides crucial information about your genetic makeup that can influence medical decisions regarding surgery, pregnancy management, and long-term health monitoring.
Who Should Consider Factor V Mutation Screening?
This essential genetic screening is particularly recommended for individuals experiencing:
- Unexplained blood clots or thrombotic events
- Family history of venous thromboembolism
- Recurrent pregnancy loss or complications
- Planned major surgical procedures
- Hormone replacement therapy or oral contraceptive use
- Unexplained stroke at a young age
- Multiple miscarriages or stillbirths
- Personal history of deep vein thrombosis
Special Considerations for Testing
While a doctor’s prescription is generally required for Factor V Mutation Screening, exceptions apply for individuals planning surgery, pregnancy management, or international travel. Our testing process accommodates these specific needs while maintaining the highest standards of medical accuracy and patient care.
Benefits of Factor V Mutation Screening
Undergoing Factor V Mutation Screening provides numerous significant advantages:
- Early Risk Identification: Detect genetic predisposition before clotting events occur
- Personalized Prevention: Implement targeted preventive measures based on your genetic profile
- Informed Medical Decisions: Guide treatment choices for surgery, pregnancy, and medication use
- Family Planning Insights: Understand inherited risk factors for future generations
- Comprehensive Health Management: Develop long-term monitoring strategies for optimal health
- Peace of Mind: Gain clarity about your genetic thrombophilia status
Understanding Your Test Results
Your Factor V Mutation Screening results will fall into one of three categories:
Normal Result (Negative)
A negative result indicates the absence of the Factor V Leiden mutation. This suggests you do not carry this specific genetic risk factor for inherited thrombophilia. However, it’s important to remember that other genetic and acquired factors can still contribute to clotting risk.
Heterozygous Mutation
This result indicates you carry one copy of the Factor V Leiden mutation. Individuals with heterozygous status have approximately 3-8 times increased risk of venous thrombosis compared to the general population. Your healthcare provider will discuss appropriate preventive measures and monitoring strategies.
Homozygous Mutation
A homozygous result means you carry two copies of the Factor V Leiden mutation, significantly increasing your thrombotic risk (up to 80 times higher than normal). This finding requires comprehensive medical management and careful planning for surgeries, pregnancies, and other high-risk situations.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | Factor V Mutation Screening F5 G1691A |
| Regular Price | $200 USD |
| Discount Price | $150 USD |
| Turnaround Time | 3-4 Days |
| Sample Type | Peripheral Blood |
| Test Components | EDTA Vacutainer (2ml) |
| Testing Method | Real Time PCR |
Nationwide Testing Availability
We proudly offer Factor V Mutation Screening services across the United States, with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our nationwide network ensures accessible, reliable genetic testing for patients throughout the country.
Take Control of Your Genetic Health Today
Understanding your Factor V mutation status represents a crucial step in proactive health management. Whether you’re planning surgery, considering pregnancy, or simply want to understand your inherited risk factors, this screening provides invaluable insights. Our advanced Real Time PCR technology delivers accurate, reliable results within 3-4 days, empowering you and your healthcare provider to make informed medical decisions.
Ready to schedule your Factor V Mutation Screening? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic thrombophilia risk and implementing effective prevention strategies for long-term health and wellness.
